Mia's Feed
Medical News & Research

Study Reveals Risks of Excessive Medication Use and Hospital Visits Among Older Adults

Study Reveals Risks of Excessive Medication Use and Hospital Visits Among Older Adults

Share this article

A new study from the University of Bath reveals that excessive medication use among seniors increases the risk of emergency hospitalizations, emphasizing the need for proactive medication management and innovative assessment tools.

2 min read

A recent study conducted by the University of Bath in the UK highlights that excessive and unnecessary medication, known as inappropriate polypharmacy, significantly increases the risk of emergency hospital admissions for seniors aged 65 and older. The research emphasizes that multiple medications, particularly those with sedative and anticholinergic effects, contribute to a higher chance of adverse health events leading to hospitalization.

The study utilized a comprehensive UK dataset and developed machine learning models to predict the likelihood of hospitalization within 30 days. Key predictors included the Drug Burden Index (DBI), which measures the cumulative impact of medications with sedative and anticholinergic properties, alongside factors like impaired mobility, history of falls or fractures, smoking, and alcohol consumption. Results demonstrated an approximately 75% accuracy in identifying at-risk individuals.

The findings shed light on the dangers of prescribing cascades, where side effects from one medication lead to additional prescriptions, compounding health risks. As older adults often manage chronic conditions like diabetes, hypertension, and arthritis with multiple drugs, this escalating complexity can lead to harmful drug interactions and increased hospitalization risk.

Researchers suggest the development of a digital tool—potentially an app—that healthcare professionals can use to assess a patient's risk based on medication use, lifestyle, and health history. Such a tool could enable proactive adjustments to treatment plans and lifestyle interventions, preventing hospital visits and improving patient safety. The study underscores the importance of careful medication management in geriatric care and aims to enhance clinical decision-making to support safer aging.

While the research was based on UK data, the issue of polypharmacy is a global concern, with studies worldwide linking it to adverse outcomes. The team envisions early intervention strategies that combine technology and personalized assessments to reduce preventable hospitalizations, ultimately contributing to better health outcomes for older populations.

source: https://medicalxpress.com/news/2025-07-medicines-hospital-highlights-hidden-older.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Link Between Mononucleosis and Increased Risk of Rare Liver Disease

New research reveals a strong link between infectious mononucleosis caused by Epstein-Barr virus and an increased risk of developing primary sclerosing cholangitis, a rare liver disease. The findings suggest that prevention of mono could reduce PSC risk, opening new avenues for treatment strategies.

Innovative Jawbone Organoids from Patient-Derived iPS Cells Advance Bone Disease Research and Treatments

A groundbreaking study from Kyoto University introduces jawbone-like organoids derived from patient iPS cells, enabling advanced research into bone diseases and regenerative therapies, including models for osteogenesis imperfecta.

Understanding Vaccine Choices Through Game Theory and Their Impact on Public Health

Learn how game theory explains why reasonable parents may choose not to vaccinate, leading to outbreaks, and how understanding these decision-making processes can improve public health strategies.

Innovative Therapy Targets Astrocytes to Enhance Immune Response Against Glioblastoma

A novel therapeutic approach aims to enhance immune responses against glioblastoma by targeting astrocytes that suppress T cell activity, potentially opening new avenues for treatment.